| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lin Zhu, Genxun Li, Seok Rye Choi, Karl Plössl, Piu Chan, Hongwen Qiao, Zhihao Zha, Hank F Kun. An improved preparation of [18F]FPBM: a potential serotonin transporter (SERT) imaging agent. Nuclear medicine and biology. vol 40. issue 8. 2014-06-02. PMID:24035549. |
in vivo positron emission tomography (pet) imaging of the serotonin transporter (sert) is a valuable tool in drug development and in monitoring brain diseases with altered serotonergic function. |
2014-06-02 |
2023-08-12 |
Not clear |
| S Migliarini, G Pacini, B Pelosi, G Lunardi, M Pasqualett. Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Molecular psychiatry. vol 18. issue 10. 2014-05-29. PMID:23007167. |
lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. |
2014-05-29 |
2023-08-12 |
mouse |
| S Migliarini, G Pacini, B Pelosi, G Lunardi, M Pasqualett. Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Molecular psychiatry. vol 18. issue 10. 2014-05-29. PMID:23007167. |
thanks to the specific expression of the egfp, we could highlight the serotonergic system independently of 5-ht immunoreactivity. |
2014-05-29 |
2023-08-12 |
mouse |
| S Migliarini, G Pacini, B Pelosi, G Lunardi, M Pasqualett. Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Molecular psychiatry. vol 18. issue 10. 2014-05-29. PMID:23007167. |
we found that lack of central serotonin produces severe abnormalities in the serotonergic circuitry formation with a brain region- and time- specific effect. |
2014-05-29 |
2023-08-12 |
mouse |
| S Migliarini, G Pacini, B Pelosi, G Lunardi, M Pasqualett. Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Molecular psychiatry. vol 18. issue 10. 2014-05-29. PMID:23007167. |
finally, we demonstrated that bdnf expression is significantly up-regulated in the hippocampus of mice lacking brain 5-ht, mirroring the timing of the appearance of hyperinnervation and thus unmasking a possible regulatory feedback mechanism tuning the serotonergic neuronal circuitry formation. |
2014-05-29 |
2023-08-12 |
mouse |
| M Lagière, S Navailles, L Mignon, A Roumegous, M-F Chesselet, P De Deurwaerdèr. The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates. Experimental brain research. vol 230. issue 4. 2014-05-27. PMID:23535834. |
lesions of nigrostriatal dopaminergic neurons as seen in parkinson's disease (pd) increase orofacial responses to serotonergic (5-ht) agonists in rodents. |
2014-05-27 |
2023-08-12 |
rat |
| Gergely Orban, Massimo Pierucci, Arcangelo Benigno, Mauro Pessia, Salvatore Galati, Mario Valentino, Richard Muscat, Giuseppe Di Giovann. High dose of 8-OH-DPAT decreases maximal dentate gyrus activation and facilitates granular cell plasticity in vivo. Experimental brain research. vol 230. issue 4. 2014-05-27. PMID:23780309. |
although several studies have emphasized a crucial role for the serotonergic system in the control of hippocampal excitability, the role of serotonin (5-ht) and its receptors in normal and pathologic conditions, such as temporal lobe epilepsy (tle), is still unclear. |
2014-05-27 |
2023-08-12 |
rat |
| Philippe Huot, Susan H Fo. The serotonergic system in motor and non-motor manifestations of Parkinson's disease. Experimental brain research. vol 230. issue 4. 2014-05-27. PMID:23811734. |
the serotonergic (5-ht) system is one of these and has been extensively studied in pd. |
2014-05-27 |
2023-08-12 |
Not clear |
| Andrea Godino, Soledad Pitra, Hugo F Carrer, Laura Viva. Body sodium overload modulates the firing rate and fos immunoreactivity of serotonergic cells of dorsal raphe nucleus. PloS one. vol 8. issue 9. 2014-05-27. PMID:24073217. |
in order to determine whether serotonergic (5ht) dorsal raphe nucleus (drn) cells are involved in body sodium status regulation, the effect of a s.c. infusion of either 2 m or 0.15 m nacl on 5ht drn neuron firing was studied using single unit extracellular recordings. |
2014-05-27 |
2023-08-12 |
rat |
| Lærke Toftegård Andersen, Melissa Voigt Hansen, Jacob Rosenberg, Ismail Gögenu. Pharmacological treatment of depression in women with breast cancer: a systematic review. Breast cancer research and treatment. vol 141. issue 3. 2014-05-27. PMID:24077731. |
of the six studies, three were placebo-controlled randomized controlled clinical trials with fluoxetine, a selective serotonin reuptake inhibitor; and mianserin—a noradrenergic and specific serotonergic antidepressant. |
2014-05-27 |
2023-08-12 |
Not clear |
| Silvia Franzellitti, Sara Buratti, Marco Capolupo, Bowen Du, Samuel P Haddad, C Kevin Chambliss, Bryan W Brooks, Elena Fabbr. An exploratory investigation of various modes of action and potential adverse outcomes of fluoxetine in marine mussels. Aquatic toxicology (Amsterdam, Netherlands). vol 151. 2014-05-22. PMID:24361074. |
because fx acts as a selective serotonin (5-ht) re-uptake inhibitor increasing serotonergic neurotransmission at mammalian synapses, cell signaling alterations triggered by 5-ht receptor occupations were assessed. |
2014-05-22 |
2023-08-12 |
Not clear |
| Zheng Ye, Ellemarije Altena, Cristina Nombela, Charlotte R Housden, Helen Maxwell, Timothy Rittman, Chelan Huddleston, Charlotte L Rae, Ralf Regenthal, Barbara J Sahakian, Roger A Barker, Trevor W Robbins, James B Row. Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease. Brain : a journal of neurology. vol 137. issue Pt 4. 2014-05-21. PMID:24578545. |
these results contribute to a broader understanding of the critical roles of serotonin in regulating cognitive and behavioural control, as well as new strategies for patient stratification in clinical trials of serotonergic treatments in parkinson's disease. |
2014-05-21 |
2023-08-12 |
human |
| Thorsten Lau, Felix Heimann, Dusan Bartsch, Patrick Schloss, Tillmann Webe. Nongenomic, glucocorticoid receptor-mediated regulation of serotonin transporter cell surface expression in embryonic stem cell derived serotonergic neurons. Neuroscience letters. vol 554. 2014-05-16. PMID:24021805. |
nongenomic, glucocorticoid receptor-mediated regulation of serotonin transporter cell surface expression in embryonic stem cell derived serotonergic neurons. |
2014-05-16 |
2023-08-12 |
mouse |
| Thorsten Lau, Felix Heimann, Dusan Bartsch, Patrick Schloss, Tillmann Webe. Nongenomic, glucocorticoid receptor-mediated regulation of serotonin transporter cell surface expression in embryonic stem cell derived serotonergic neurons. Neuroscience letters. vol 554. 2014-05-16. PMID:24021805. |
the hpa-axis and serotonergic (5-ht) neurons exert reciprocal regulatory actions. |
2014-05-16 |
2023-08-12 |
mouse |
| Thorsten Lau, Felix Heimann, Dusan Bartsch, Patrick Schloss, Tillmann Webe. Nongenomic, glucocorticoid receptor-mediated regulation of serotonin transporter cell surface expression in embryonic stem cell derived serotonergic neurons. Neuroscience letters. vol 554. 2014-05-16. PMID:24021805. |
these postmitotic 5-ht neurons express all relevant serotonergic markers following the application of a growth factor-based differentiation protocol. |
2014-05-16 |
2023-08-12 |
mouse |
| Maya Amitai, Sefi Kronenberg, Tali Cohen, Amos Frisch, Abraham Weizman, Alan Apte. [Pharmacogenetics and anxiety disorders: analysis of recent findings]. Harefuah. vol 153. issue 3-4. 2014-05-15. PMID:24791568. |
the primary pharmacogenetic-dynamic findings are related to serotonergic genes of which those with the long allele of the serotonin transporter gene (5-httlpr) are expected to respond positively to treatment, and the same is true regarding genetic variants of several serotonin receptors. |
2014-05-15 |
2023-08-13 |
Not clear |
| Andrew C Parrot. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users. Neuroscience and biobehavioral reviews. vol 37. issue 8. 2014-05-08. PMID:23660456. |
serotonergic neurotoxicity following mdma is well-established in laboratory animals, and neuroimaging studies have found lower serotonin transporter (sert) binding in abstinent ecstasy/mdma users. |
2014-05-08 |
2023-08-12 |
Not clear |
| Saki Shimizu, Yuto Mizuguchi, Yukihiro Ohn. Improving the treatment of schizophrenia: role of 5-HT receptors in modulating cognitive and extrapyramidal motor functions. CNS & neurological disorders drug targets. vol 12. issue 6. 2014-05-08. PMID:23844689. |
this article reviews the functional roles and mechanisms of 5-ht receptors in the treatment of schizophrenia, focusing on the serotonergic modulation of cognitive and extrapyramidal motor functions, and illustrates future therapeutic strategies. |
2014-05-08 |
2023-08-12 |
Not clear |
| José Ángel García-Pedraza, Mónica García, María Luisa Martín, Jesús Gómez-Escudero, Alicia Rodríguez-Barbero, Luis San Román, Asunción Morá. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats. European journal of pharmacology. vol 714. issue 1-3. 2014-05-06. PMID:23769743. |
experimental 5-ht₂ receptor blockade induces changes in the 5-ht receptors involved in the serotonergic inhibition of sympathetic-induced pressor responses. |
2014-05-06 |
2023-08-12 |
rat |
| José Ángel García-Pedraza, Mónica García, María Luisa Martín, Jesús Gómez-Escudero, Alicia Rodríguez-Barbero, Luis San Román, Asunción Morá. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats. European journal of pharmacology. vol 714. issue 1-3. 2014-05-06. PMID:23769743. |
the antagonism of 5-ht₂ receptors produces an enhancement of serotonergic sympathoinhibitory effect, which may explain the beneficial effects of this blockade in cardiovascular disorders where 5-hydroxytryptamine plays a crucial role. |
2014-05-06 |
2023-08-12 |
rat |